Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment
- Type: Workshop
- Track: N/A
- Presentations: 23
- Moderators:Kenneth John O'Byrne
- Coordinates: 8/06/2022, 08:00 - 11:00, Lehar 4
-
+
WS04.05 - Discussant
08:40 - 08:50 | Author(s): Aaron Scott Mansfield
- Abstract
Loading... -
+
WS04.05 - Discussant
08:40 - 08:50 | Author(s): Aaron Scott Mansfield
- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Presentations: 34
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.01-011 - Real World Outcomes of Durvalumab after Chemoradiotherapy in unresectable advanced Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Author(s): Joel Rivera Concepcion- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 172
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-037 - Small Cell Transformation in a Patient with RET Fusion Positive Lung Adenocarcinoma on Pralsetinib.
Author(s): Anastasios Dimou- Abstract
Loading...
-
+
P2.14 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Presentations: 4
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.14-03 - Restored Ubiquitination and Degradation of Exon 14 Skipped MET with Proteolysis Targeting Chimeras
Author(s): Aaron Scott Mansfield- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 13
- Moderators:Lorenza Landi
- Coordinates: 8/09/2022, 12:00 - 13:00, Hall C7
-
+
MA13.09 - Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
12:37 - 12:42 | Author(s): Sagar Rakshit
- Abstract
Loading...